Literature DB >> 1377010

Chromosome aberrations in 35 primary ovarian carcinomas.

T Pejovic1, S Heim, N Mandahl, B Baldetorp, B Elmfors, U M Flodérus, S Furgyik, G Helm, A Himmelmann, H Willén.   

Abstract

Cytogenetic analysis was performed on short-term cultures of primary ovarian carcinomas from 62 patients. Cytogenetic analysis was successful in 59 cases. Clonal chromosome aberrations were detected in 35 tumors. Only numerical changes or a single structural change were found in five carcinomas: trisomy 12 was the sole anomaly in two tumors, one tumor had the karyotype 50,XX, + 5, + 7, + 12, + 14, a fourth tumor had a balanced t(1;5), and the fifth tumor had an unbalanced t(8;15). The fact that four of these five carcinomas were well differentiated suggests that simple karyotypic changes are generally characteristic of these less aggressive ovarian tumors. The majority of the cytogenetically abnormal tumors (n = 30) had complex karyotypes, with both numerical and structural aberrations and often hypodiploid or near-triploid stemlines. The numerical imbalances (comparison with the nearest euploid number) were mostly losses, in order of decreasing frequency -17, -22, -13, -8, -X, and -14. The structural aberrations were mostly deletions and unbalanced translocations. Recurrent loss of genetic material affected chromosome arms 1p, 3p, 6q, and 11p. The breakpoints of the clonal structural abnormalities clustered to several chromosome bands and segments: 19p13, 11p13-15, 1q21-23, 1p36, 19q13, 3p12-13, and 6q21-23. The most consistent change (16 tumors) was a 19p + marker, and in 12 of the tumors the 19p + markers looked alike.

Entities:  

Mesh:

Year:  1992        PMID: 1377010     DOI: 10.1002/gcc.2870040108

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  22 in total

1.  mFISH analysis of chromosome aberrations in workers occupationally exposed to mixed radiation.

Authors:  Natalia V Sotnik; Sergey V Osovets; Harry Scherthan; Tamara V Azizova
Journal:  Radiat Environ Biophys       Date:  2014-04-09       Impact factor: 1.925

2.  Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity.

Authors:  D Gisselsson; L Pettersson; M Höglund; M Heidenblad; L Gorunova; J Wiegant; F Mertens; P Dal Cin; F Mitelman; N Mandahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.

Authors:  Jane Bayani; Paula Marrano; Cassandra Graham; Yingye Zheng; Lin Li; Dionyssios Katsaros; Heini Lassus; Ralf Butzow; Jeremy A Squire; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-08-11       Impact factor: 6.603

4.  Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

Authors:  D L Persons; L C Hartmann; J F Herath; T J Borell; W A Cliby; G L Keeney; R B Jenkins
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

5.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

Authors:  J Q Cheng; A K Godwin; A Bellacosa; T Taguchi; T F Franke; T C Hamilton; P N Tsichlis; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

6.  Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.

Authors:  Paule Héléna Yoffou; Lydia Edjekouane; Liliane Meunier; André Tremblay; Diane Michèle Provencher; Anne-Marie Mes-Masson; Euridice Carmona
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

7.  Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line-IPO43.

Authors:  Fernanda Silva; Filipa Coelho; Ana Peixoto; Pedro Pinto; Carmo Martins; Ann-Sophie Frombach; Vítor E Santo; Catarina Brito; António Guimarães; Ana Félix
Journal:  Cancer Cell Int       Date:  2022-04-30       Impact factor: 6.429

8.  Expression of cyclin D1 correlates with malignancy in human ovarian tumours.

Authors:  F Barbieri; M Cagnoli; N Ragni; F Pedullà; G Foglia; A Alama
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.

Authors:  Y Hatta; S Takeuchi; J Yokota; H P Koeffler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Vera M Abeler; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Oncol       Date:  2009-09-15       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.